Deciphering an outbreak of drug-resistant Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 41, Issue 1, 2003, Pages 67-72

  Dahle, Ulf R ^a   Sandven, Per ^a   Heldal, Einar ^a   Mannsaaker, Turid ^b   Caugant, Dominique A ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; ANTIMYCOBACTERIAL AGENT; AZITHROMYCIN; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE;

ADULT; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYBRIDIZATION; IMMIGRANT; INCIDENCE; KATG GENE; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NORWAY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RPOB GENE; SCREENING; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; CHILD; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; SOMALIA; UNCULTURED ACTINOMYCETE;

EID: 0037234344     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.1.67-72.2003     Document Type: Article

References (24)

1. Abate, G., S. Hoffner, V. Ostergaard, and H. Miörner. 2001. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur. J. Clin. Microbiol. Infect. Dis. 20:329-333.
2. Callister, M. E. J., J. Barringer, S. T. Thanabalasingam, R. Gair, and R. N. Davidson. 2002. Pulmonary tuberculosis among political asylum seekers screened at Heathrow Airport, London, 1995-9. Thorax 57:152-156.
3. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, B. G. Barrell, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
4. Dahle, U. R., P. Sandven, E. Heldal, and D. A. Caugant. 2001. Molecular epidemiology of Mycobacterium tuberculosis in Norway. J. Clin. Microbiol. 39:1802-1807.
5. Daley, C. L. 2002. Transmission of multidrug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 165:742-743.
6. Dye, C., M. A. Espinal, C. J. Watt, C. Mbiaga, and B. G. Williams. 2002. Worldwide incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 185:1197-1202.
7. Fluit, A. C., M. R. Visser, and F.-J. Schmitz. 2001. Molecular detection of antimicrobial resistance. Clin. Microbiol. Rev. 14:836-871.
8. Hargreaves, S. 2000. System to detect tuberculosis in new arrivals to UK must be improved. Br. Med. J. 320:870.
9. Heldal, E. 2001. Tuberculosis in Norway 2000. Rep. Syst. Communic. Dis. 29:18.
10. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
11. Klovdahl, A. S., E. A. Graviss, A. Yaganehdoost, M. W. Ross, A. Wagner, G. J. Adams, and J. M. Musser. 2001. Networks and tuberculosis: an undetected community outbreak involving public places. Soc. Sci. Med. 52:681-694.
12. Lillebaek, T., Å. Andresen, J. Bauer, A. Dirksen, S. Glismann, P. de Haas, and A. Kok-Jensen. 2001. Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J. Clin. Microbiol. 39:855-861.
13. Maguire, H., J. W. Dale, T. D. McHugh, P. D. Butcher, S. H. Gillespie, A. Costetsos, H. Al-Ghusein, R. Holland, A. Dickens, L. Marston, P. Wilson, R. Pitman, D. Strachan, F. A. Drobniewski, and D. K. Banerjee. 2002. Molecular epidemiology of tuberculosis in London 1995 to 1997 showing low rate of active transmission. Thorax 57:617-622.
14. Maiden, M. C. J., J. A. Bygraves, E. Feil, G. Morelli, J. E. Russel, R. Urwin, Q. Zhang, J. Zhou, K. Zurth, D. A. Caugant, I. M. Feavers, M. Achtman, and B. G. Spratt. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA 95:3140-3145.
15. Marttila, H. J., H. Soini, P. Huovinen, and M. K. Viljanen. 1996. katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob. Agents Chemother. 40:2187-2189.
16. Nitta, A. T., L. S. Knowles, J. Kim, E. L. Lehnkering, L. A. Borenstein, P. T. Davidson, S. M. Harvey, and M. L. De Koning. 2002. Limited transmission of multidrug-resistant tuberculosis despite a high proportion of infectious cases in Los Angeles county, California. Am. J. Respir. Crit. Care Med. 165:812-817.
17. Siddiqi, S. H., J. P. Libonati, and G. Middlebrook. 1981. Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 13:908-913.
18. van Doorn, H. R., E. J. Kuijper, A. van der Ende, A. G. A. Welten, D. van Soolingen, P. E. W. de Haas, and J. Dankert. 2001. The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg→Leu mutation at codon 463 of katG are not associated. J. Clin. Microbiol. 39:1591-1594.
19. van Embden, J. D. A., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, and P. M. Small. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
20. van Soolingen, D., M. W. Borgdorff, P. E. de Haas, M. M. Sebek, J. Veen, M. Dessens, K. Kremer, and J. D. van Embden. 1999. Molecular epidemiology of tuberculosis in The Netherlands: a nationwide study from 1993 through 1997. J. Infect. Dis. 180:726-736.
21. van Soolingen, D., P. E. de Haas, H. R. van Doorn, E. Kuijper, H. Rinder, and M. W. Borgdorff. 2000. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in The Netherlands. J. Infect. Dis. 182:1788-1790.
22. World Health Organization. 1994. Tuberculosis - a global emergency. W. H. O. report on the TB epidemic. World Health Organization, Geneva, Switzerland.
23. World Health Organization. 1997. W. H. O. report on the tuberculosis epidemic. World Health Organization, Geneva, Switzerland.
24. World Health Organization. 2000. Anti-tuberculosis drug resistance in the world, report no. 2. The W. H. O./IUATLD global project on anti-tuberculosis drug resistance surveillance 1997-2000. World Health Organization, Geneva, Switzerland.